Technetium Tc 99m sulfur colloid injection - Pharmalucence

Drug Profile

Technetium Tc 99m sulfur colloid injection - Pharmalucence

Alternative Names: AN-Sulfur Colloid - Pharmalucence; Kit for the preparation of Technetium Tc 99m sulfur colloid injection (SCI) - Pharmalucence; Tc 99m sulfur colloid kit

Latest Information Update: 22 Aug 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pharmalucence
  • Class Imaging agents; Inorganic sulfur compounds; Organotechnetium compounds; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Technetium compounds
  • Mechanism of Action Ionising radiation emitters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Malignant melanoma
  • New Molecular Entity No

Highest Development Phases

  • Marketed Breast cancer; Malignant melanoma

Most Recent Events

  • 16 Aug 2012 Launched for Malignant melanoma (diagnosis; localisation of lymph nodes) in USA (SC)
  • 16 Aug 2012 Registered for Malignant melanoma (diagnosis; localisation of lymph nodes) in USA (SC)
  • 16 Aug 2012 Technetium Tc 99m sulfur colloid injection - Pharmalucence receives Orphan Drug status for Malignant melanoma (localisation of lymph nodes) in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top